0001209191-16-135037.txt : 20160802 0001209191-16-135037.hdr.sgml : 20160802 20160802180723 ACCESSION NUMBER: 0001209191-16-135037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160801 FILED AS OF DATE: 20160802 DATE AS OF CHANGE: 20160802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RINGO WILLIAM R CENTRAL INDEX KEY: 0001238325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 161801747 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-01 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001238325 RINGO WILLIAM R TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2016-08-01 4 M 0 500 11.65 A 500 D Common Stock 2016-08-01 4 S 0 500 50.77 D 0 D Stock Option (right to buy) 50.77 2016-08-01 4 S 0 500 0.00 D 2024-09-30 Common Stock 500 0 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 15, 2016. The shares underlying the option will vest at a rate of one-third per year on each anniversary of the grant date. /s/ Francis Sarena, Attorney-in-Fact 2016-08-02